ANTX – an2 therapeutics, inc. (US:NASDAQ)

Sec Filings

Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Commodore Capital LP
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.
Form 8-K AN2 Therapeutics, Inc. For: Mar 08
Form 4 AN2 Therapeutics, Inc. For: Mar 03 Filed by: Williams Sarah Joanne
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com